Validated method for the quantitation of quercetin from human plasma using high-performance liquid chromatography with electrochemical detection

https://doi.org/10.1016/S0378-4347(99)00049-3Get rights and content

Abstract

A validated method for the quantitation of trace levels of quercetin from human plasma to be used in pharmacokinetic and biomarker studies is presented. Quercetin conjugates were hydrolysed enzymatically, plasma proteins were removed using a Bond Elut C18 extraction column and additional interferences were removed by extracting them into a toluene–dichloromethane mixture. The HPLC system consisted of an Inertsil ODS-3 column (250×4.0 mm) and a mobile phase with 59% methanol in phosphate buffer (pH 2.4). High selectivity and a low quantitation limit (0.63 μg/l) were achieved by using electrochemical detection at a low potential. The method has excellent reproducibility: R.S.D. values of peak-heights were 2% and 7.9%, respectively, for within-day and between-day precision. The method was applied to a small scale study of quercetin pharmacokinetics and quercetin was shown to be absorbed from a 20 mg dose. No free quercetin was detected in plasma and no evidence of significant amounts of quercetin glycosides in plasma was found.

Introduction

The flavonoids are a group of polyphenols widely occurring in the plant kingdom. One of the flavonoid subclasses, the flavonols, and particularly quercetin, has received much attention during the past few years. Quercetin has been reported to have many biological activities, such as antioxidant, antithrombotic, anti-inflammatory and anticarcinogenic activities [1]. Epidemiological studies suggest that dietary flavonols, including quercetin, could prevent coronary heart disease [2] and cancer [3]. Quercetin is one of the most abundant flavonoids in the diet with an intake estimated as 2.6–38.2 mg per day [4]. The compound is mainly present as glycosides in foods, with the aglycone form being quite rare. The structures of quercetin aglycone and quercetin glycosides present in onions (spireaoside) and tea (rutin), are shown in Fig. 1.

Although in vitro studies and animal experiments show that quercetin and other flavonoids are biologically active in many respects, it has been difficult to draw any definite conclusions about their relevance to human health. Analytical methods suitable for the measurement of quercetin from human tissues have only been available for a few years. They have mainly been based on HPLC with UV-detection [5], [6], [7], [8], [9], which lacks both the selectivity and sensitivity required, when analyzing low levels of quercetin in plasma. Recently, analytical methods with lower detection limits, based on HPLC with fluorometric [10] or electrochemical [11], [12] detection, have been introduced. Little validation data, however, or data about the stability of quercetin during the different steps of analysis, have been presented. Previous reports [13], [14], [15] and preliminary experiments in our laboratory have shown that quercetin is unstable under various conditions.

Information about the different forms of quercetin present in plasma is scarce. This information is relevant, because conjugation can considerably affect the biological activity of a compound. It has been assumed that quercetin, as many other compounds, is conjugated with glucuronide and/or sulfate groups in the liver [16]. Quercetin could also be present in plasma as glycosides, as proposed by Hollman et al. [17]. In one study [18], large amounts of rutin and other quercetin glycosides were found in plasma of unsupplemented subjects, by using HPLC with diode-array detection, and UV-spectra for identification.

This paper describes a reproducible, sensitive and selective method for the quantitation of trace levels of quercetin aglycone in plasma. The method can be used in supplementation studies and when analyzing quercetin in plasma of unsupplemented subjects. In this report, the method was applied to a small scale study of quercetin pharmacokinetics. We also attempted to assess whether unconjugated quercetin or quercetin glycosides are present in plasma.

Section snippets

Reagents and chemicals

Quercetin, rutin, epicatechin, (+)-catechin, tert.-butylhydroquinone (TBHQ), butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), dithiothreitol (DTT), ubiquinone (Q10), β-glucosidase, β-glucuronidases (type HP-2, B and IX-A) and sulfatase (type V) were obtained from Sigma (St. Louis, MA, USA). Spireaoside was purchased from Extrasynthese (Genay, France). Trolox, (R)-(+)-trolox and (S)-(−)-trolox were obtained from Aldrich Chem. Co. (Milwaukee, WI, USA). Ascorbic acid, oxalic acid,

Chromatography

Representative chromatograms of low-quercetin and high-quercetin plasma extracts are shown in Fig. 2. The retention time of quercetin was 7.8 min. The HPLC column used, Inertsil ODS-3, was superior to the other HPLC columns tested, giving a quercetin peak with least tailing.

The detector was set to +100 mV, although the maximum response for a quercetin standard was achieved at much higher potentials. When the oxidation was done at a potential this low, the method was extremely selective and

Conclusions

This paper describes a validated method for the quantitation of trace levels of quercetin in human plasma. The method has excellent precision, reproducibility and sensitivity. Special attention has been paid to the stability of quercetin during the different steps of analysis. The method can be used when measuring quercetin in plasma of non-supplemented and supplemented subjects, and is therefore suitable for both supplementation studies and biomarker studies.

The method was applied to a small

Acknowledgements

The excellent technical assistance of Eva Kammiovirta is acknowledged. The authors also want to thank the volunteers participating in the study. This work was supported by the Finnish Heart Research Foundation, Juho Vainio Foundation, Yrjö Jahnsson Foundation and the project ‘Nutritional quality and safety of Finnish foods’.

References (23)

  • N.C. Cook et al.

    J. Nutr. Biochem.

    (1996)
  • M.G.L. Hertog et al.

    Lancet

    (1993)
  • B. Liu et al.

    J. Chromatogr. B

    (1995)
  • C. Manach et al.

    J. Nutr.

    (1995)
  • J.A. Conquer et al.

    J. Nutr.

    (1998)
  • D. Bongartz et al.

    J. Chromatogr. B

    (1995)
  • S.E. Nielsen et al.

    J. Chromatogr. B

    (1998)
  • P.C.H. Hollman et al.

    Free Radical Biol. Med.

    (1996)
  • C. Manach et al.

    FEBS Lett.

    (1998)
  • M.S. Masri et al.

    Arch. Biochem. Biophys.

    (1959)
  • G. Paganga et al.

    FEBS Lett.

    (1997)
  • Cited by (84)

    • Enhanced anti-amnestic effect of donepezil by Ginkgo biloba extract (EGb 761) via further improvement in pro-cholinergic and antioxidative activities

      2021, Journal of Ethnopharmacology
      Citation Excerpt :

      To ensure the stability of bilobalide, an aliquot of 100 μl brain homogenate was treated with 10 μl 0.1 M ascorbic acid before storage at −80 °C until analyses as suggested by others (Zhao et al., 2008). For quantification of EGb components in plasma/brain, an aliquot of 110 μl thawed plasma/brain sample was mixed with 20 μl of 2 μg/ml diclofenac (IS) solution followed by incubation with 11 μl of 0.78 M sodium acetate buffer (pH = 4.8) and 4 μl of 5000 U/ml β-glucuronidase at 37 °C (Erlund et al., 1999). After 30 min incubation, around 1.2 ml ethyl acetate was added to the cooled sample followed by vortex for 10 min.

    • Optical and calorimetric studies of quercetin-doped liquid crystals: Effects of molecular aggregation

      2019, Journal of Molecular Liquids
      Citation Excerpt :

      The separation and determination of various flavonoids is rather complex and challenging task. For detection of quercetin different methods have been applied, such as capillary electrophoresis, gas chromatography, liquid chromatography with electrochemical detection or colorimetric detection, ultra-violet spectrophotometry, flow injection analysis and pulse polarography [33–35]. Recently for selective detection and sensing of quercetin different innovative methods have been proposed, using carbon nanotubes modified glassy carbon electrodes [36], manganese-doped ZnS quantum dots [37], luminescent organosilane-functionalized carbon dots [38], core–shell magnetic molecularly imprinted polymers [39], and metal-organic frameworks [40].

    • Pharmacokinetic properties of phytochemicals in Hypericum perforatum influence efficacy of regulating oxidative stress

      2019, Phytomedicine
      Citation Excerpt :

      The biological data (Fig. 2) showed a sustained reduction (2–4 h) in the stress biomarker prolactin beyond the predicted period of peak antioxidant accumulation (1.6–2.3 h) following ingestion of H. perforatum. This may be accounted for by the extended Tmax of quercetin due to deglycosylation of quercetin glycosides and the extended elimination half-life of quercetin (T1/2 = 15.1–24.2 h, Figure S2), which suggests that its antioxidant effect is likely sustained beyond the PCAP predicted Tmax (Erlund et al., 1999; Erlund et al., 2000; Wang et al., 2015). Accordingly, H. perforatum provides long-lasting protection against OSI from 1.6 h post ingestion, coinciding with the Tmax of the antioxidant quercetin.

    • Improved Characterization of Polyphenols Using Liquid Chromatography

      2014, Polyphenols in Plants: Isolation, Purification and Extract Preparation
    • Mixed hemimicelles solid-phase extraction based on ionic liquid-coated Fe<inf>3</inf>O<inf>4</inf>/SiO<inf>2</inf> nanoparticles for the determination of flavonoids in bio-matrix samples coupled with high performance liquid chromatography

      2014, Journal of Chromatography A
      Citation Excerpt :

      In order to probe the potential benefits, or adverse effects of different flavonoids consumption more efficiently, it is necessary to develop analytical methods capable of sensitively, accurately and simultaneously quantifying of a number of trace amounts of flavonoids in human fluids. Several methods have been described for the determination of flavonoids in biological samples, including HPLC–UV in plasma [4] and urine [5], HPLC with fluorometric detection in plasma and urine [6], HPLC-ED (electrochemical detection) in plasma [7], and a GC–MS method [8]. However, these methods are deficient when the flavonoid concentration is extremely low or there is interference of complex matrix in biological samples.

    View all citing articles on Scopus
    View full text